Bernstein on Oracle (ORCL): 'Time to Buy Any Weakness'; PT Lowered to $207
Tweet Send to a Friend
Bernstein SocGen Group analyst Mark L. Moerdler lowered the price target on Oracle (NYSE: ORCL) to $207.00 (from $213.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
